Mumbai, June 25 -- The domestic equity indices traded with modest gains in the early afternoon trade. The Nifty traded above 25,200 level. The Nifty traded above the 25,250 mark. Metal shares witness... Read More
Mumbai, June 25 -- Arihant Foundations & Housingannounced the acquisition of a strategically located 3-acre land parcel on MGR Salai, Perungudi situated at the gateway to the city's thriving IT corrid... Read More
Mumbai, June 25 -- Happy Forgings has fixed 22 July 2025 as record date for payment of final dividend of Rs 3 per equity share of Rs 2 each for FY 2024-25. Published by HT Digital Content Services wi... Read More
Mumbai, June 25 -- The approved dosages-10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg-are indicated for the treatment of symptoms of depression. Amitriptyline Hydrochloride is a tricyclic antidepress... Read More
Mumbai, June 25 -- Deep Polymers Ltd, Solara Active Pharma Sciences Ltd, Mold-Tek Technologies Ltd and DB (International) Stock Brokers Ltd are among the other gainers in the BSE's 'B' group today, 25... Read More
Mumbai, June 24 -- HDFC Mutual Fund has announced change in fund manager under the following scheme, With effect from 01 July 2025 Table, th, td {border: 1px Solid black; Border-collapse: collapse;}... Read More
Mumbai, June 24 -- The Board ofAstec LifeSciences at its meeting held on 24 June 2025 has approved the issue of fully paid-up equity shares of the company of face value of Rs. 10/- eachfor an amount n... Read More
Mumbai, June 24 -- The key equity indices traded with impressive gains in the mid-morning trade, tracking a sharp rally in Asian markets after US President Donald Trump announced a ceasefire agreement... Read More
Mumbai, June 24 -- Pandey, who currently serves as the chief risk officer, has been a founding member of Ugro Capital and has played a pivotal role in building the company's risk governance framework ... Read More
Mumbai, June 24 -- The drug is a specially designed anti-PD-1 monoclonal antibody created by BeiGene, now BeOne Medicines, which focuses on oncology. TEVIMBRA is intended for the first-line treatment... Read More